Loading the records…
Loading the records…
Veterans Affairs · NETWORK CONTRACT OFFICE 23 (36C263)
Veterans Affairs is planning to buy "Next Generation Sequencing (NGS) Reagent Kits". This is an early notice: it is not taking bids yet. The work is in Iowa City, IA, USA. Responses are due Nov 22, 2026. In the last 2 years, similar work went to 10 or more companies, usually for about $204K per award. An award is expected between December 2026 and February 2027.
Put together from the facts on this page; the details and sources are below.
Your briefs and their views: My briefs.
Every notice posted under solicitation 36C26327Q0117 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
25 award notices on SAM.gov in the last 24 months. Matched by: Same office (NETWORK CONTRACT OFFICE 23 (36C263)), same product/service code (PSC) 6640 and NAICS 334516.
Single-winner award sizes (25): middle half $66K to $534K, median $204K; range $7K to $17.8M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ABBOTT LABORATORIES INC. · $ABT · $48.2B | 3 | $19.2M | Mar 10, 2026 |
| BECTON, DICKINSON AND COMPANY |
| 3 |
| $875K |
| Jun 16, 2026 |
| WERFEN USA LLC | 2 | $2.5M | Apr 1, 2026 |
| INNOVIVE, LLC | 1 | $828K | Aug 25, 2026 |
| Hologic Sales and Service, LLC | 1 | $632K | Oct 1, 2025 |
| DIASORIN MOLECULAR, LLC | 1 | $340K | Oct 7, 2026 |
| ONE LAMBDA, INC. · $TMO · $47.4B | 1 | $325K | Sep 17, 2026 |
| Fisher Scientific Company · $TMO · $47.4B | 1 | $311K | Sep 28, 2026 |
| ABBOTT MOLECULAR INC. | 1 | $308K | Jul 7, 2026 |
| GENDX PRODUCTS LLC | 1 | $204K | Oct 1, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
One award's total value against one year of revenue; many awards are paid over several years.
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
No lobbyist on these filings lists a past Veterans Affairs, Dept of (VA) job: no revolving-door tie found in these filings. (These are lobbyists the companies pay, not their own staff.)
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
A bill's title is shown only when the filing's own text names it; filings often cite last Congress's bill numbers.
No executive order in the last 12 months names Veterans Affairs in its title or summary.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
| Company | Price | 90 days | Insiders, 90 days |
|---|---|---|---|
| $ABT ABBOTT LABORATORIES INC. | $109.40 Nov 3, 2026 | +3.5% | 0 buys, 2 sells ($68.2M, 0 marked 10b5-1) · Latest |
| $BDX BECTON, DICKINSON AND COMPANY | $176.80 Oct 2, 2026 | +11.8% | 0 buys, 3 sells ($60K, 3 marked 10b5-1) · Latest |
| $TMO ONE LAMBDA, INC. | $698.34 Nov 3, 2026 | +20.9% | 0 buys, 3 sells ($10.4M, 2 marked 10b5-1) · Latest |
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.